Latest Distributions News

BlackRock Investment Management (Australia) Limited has announced estimated cash distributions for four Australian iShares ETFs, outlining key dates and options for investors to reinvest dividends.

Pinnacle Investment Management reported an 11% drop in net profit after tax for the first half of FY26, despite record net inflows and a strategic move to fully acquire Pacific Asset Management.

Pinnacle Investment Management reported a solid 13% increase in funds under management to $202.5 billion despite an 11% drop in half-year profit. The company declared a 29 cent interim dividend and advanced its international expansion with key acquisitions.

Little Green Pharma Ltd is set to acquire Cannatrek Ltd in a transformative merger that will create one of the largest vertically integrated medicinal cannabis companies globally, with pro-forma FY25 revenue exceeding AUD 112 million.

Atlas Arteria confirms the extension of France’s temporary supplemental tax into 2026 but maintains its 40 cents per share distribution guidance, signalling confidence amid regulatory shifts.

Morella Corporation has expanded its rubidium exploration footprint at the Mt Edon Project in Western Australia, identifying multiple new high-grade targets with assays up to 2.84% Rb2O. This development strengthens the company's position in the critical minerals sector alongside its lithium assets.

Memphasys has lodged regulatory submissions for its Felix™ System in Australia and India, following CE Mark approval, while progressing UK market entry under the CE Mark transition framework.

Aroa Biosurgery’s latest business update reveals promising clinical outcomes from its Myriad trauma study and evolving reimbursement policies that could reshape its market position. The company also projects solid revenue growth for FY26, supported by strategic commercial initiatives.

Rhythm Biosciences has secured a multi-year commercial manufacturing agreement with US-based Quansys Biosciences to produce ColoSTAT® reagent kits, paving the way for broader market rollout of its colorectal cancer diagnostic test.

Aroa Biosurgery reaffirms strong FY26 guidance, buoyed by favourable US Medicare reimbursement for Symphony and promising trauma study results for Myriad.

Credit Corp delivers steady H1 FY26 results with robust US collections and record lending volumes, while pursuing a strategic acquisition to boost its consumer finance footprint.

Vection Technologies has secured a $2.2 million defence contract for its new FEDRA edge data appliance, marking a significant step in its AI-powered military technology portfolio under a $22.3 million framework agreement.